Study guide
4.1 Medical History, Physical Findings, and Gender Affirmation
ARRT Mammography Postprimary
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Postprimary Eligibility, Structured Education, and Clinical Requirements 1.3 Scoring, Retakes, Fees, and Credential Maintenance 1.4 2025 Content Outline, Domain Weights, and Study Strategy
2 Patient Communication
2.1 Pre-Exam Instructions 2.2 Explaining the Exam, Rapport, and Support 2.3 Patient Education: ACS/ACR Guidelines, BSE, CBE, Dose, and Modalities
3 Results Communication and Breast Cancer Risk
3.1 Process for Receiving Results and Additional Imaging 3.2 Epidemiology and Inherent Risk Factors 3.3 Social Risk Factors, Access, and Hormone Use 3.4 Signs and Symptoms of Breast Disease
4 History, Priors, and Treatment Context
4.1 Medical History, Physical Findings, and Gender Affirmation 4.2 Previous Mammograms 4.3 Surgical, Nonsurgical, and Reconstruction Options
5 Mammography Unit Design
5.1 kVp Range, Tube, Filtration, Window, and Focal Spot 5.2 Compression Paddles, Grids, and System Geometry
6 Digital Acquisition, Display, and Informatics
6.1 FFDM-DR/2D, DBT/3D, and Synthesized Imaging 6.2 Image Receptors and Acquisition vs Interpretation Monitors 6.3 HIS/RIS/EMR, PACS, and CAD
7 Accreditation, MQSA, EQUIP, and Density Reporting
7.1 Accreditation Bodies, FDA/MQSA Personnel, Records, Audits, and Policies 7.2 EQUIP: QA Oversight, Clinical Image Quality, and Corrective Action 7.3 Breast Density Reporting Requirements
8 Quality Control Testing
8.1 Mammographer QC: Phantom Image, Compression Thickness, Visual Checklist 8.2 Mammographer QC: Monitors, Repeat Analysis, Viewing Conditions, Compression Force, Detector Calibration 8.3 Physicist Tests: MEE, Collimation, Spatial Resolution/MTF, SNR/CNR, AEC, AGD, kVp, HVL 8.4 Physicist Tests: Artifacts, Phantom Quality, Illuminance, Tech QC Program Review, Compression Application/Paddle Alignment, Workstation QC
9 Technique and Image Evaluation
9.1 Technical Factors: kVp, mAs, AEC vs Manual, Target/Filter, Focal Spot, Grid, Mag, Labeling 9.2 EQUIP Image-Quality Criteria 9.3 Patient-Related Artifacts
10 Localization and Anatomy
10.1 Clock Position, Quadrants, and Triangulation 10.2 External Anatomy 10.3 Internal Anatomy: Fascia, Glandular Tissue, and the TDLU 10.4 Cooper Ligaments, Pectoral Muscle, Vascular/Lymphatic Systems, and Cytology
11 BI-RADS Lexicon
11.1 Architectural Distortion, Asymmetry, and Mass Features 11.2 Calcification Morphology and Distribution 11.3 Assessment Categories, Breast Density, and Recommendations
12 Breast Pathology
12.1 Benign Pathology and Mammographic Appearance 12.2 Lesions with Upgrade Potential 12.3 DCIS, IDC, and Invasive Lobular Carcinoma 12.4 Inflammatory Carcinoma, Paget Disease, Sarcoma, Lymphoma, and Metastases
13 Standard Screening Views
13.1 Craniocaudal (CC) Positioning 13.2 Mediolateral Oblique (MLO) Positioning
14 Additional Views I
14.1 Mediolateral (ML) and Lateromedial (LM) 14.2 XCCL, XCCM, Cleavage (CV), and Axillary Tail (AT) 14.3 Tangential (TAN) and Rolled Views (RL, RM, RS, RI)
15 Additional Views II
15.1 Implant Displaced (ID), Nipple in Profile, and Anterior Compression 15.2 Spot Compression and Magnification
16 Patient Variance
16.1 Chest Wall Variations, Kyphosis/Lordosis, Protruding Abdomen, and Extreme Breast Size 16.2 Irradiated Breast, Reduction Mammoplasty, and Postsurgical Breast 16.3 Male Patients and Lactating Breast 16.4 Breast Augmentation and Implanted Devices
17 Imaging Examinations
17.1 Screening vs Diagnostic Mammography 17.2 Breast Ultrasound and Breast MRI
18 Interventional Procedures
18.1 History, Consent, Time-Out, Setup, and Postprocedure Instructions 18.2 Stereotactic and Ultrasound-Guided Biopsy 18.3 Needle Localization, Specimen Imaging, and Clip Placement 18.4 Handling and Disposing of Biohazardous Materials
4.1 Medical History, Physical Findings, and Gender Affirmation
Key Takeaways Explain This Topic AI
The written order's indication (screening versus diagnostic) sets protocol; a new symptom reported at the desk is documented and escalated so the order can be amended, not ignored.
ARRT history examples for previous breast surgery are lumpectomy and augmentation; reconstruction details belong with treatment context, not as a substitute for recording the surgery itself.
Lumps, scars, moles, tattoos, and other abnormalities are documented with radiopaque skin markers and/or a breast diagram, never by verbal description alone.
Gender-affirming surgery and hormonal therapy are medical-history items because they change remaining breast tissue and the screening pathway the order should follow.
A common marker convention uses a triangle for a palpable lump, a thin line for a scar, a circle for a mole, and a BB for a nipple that is not in profile; follow the facility protocol.
Last updated: August 2026
Why This History Stop Is Scored
Patient Care on the ARRT Mammography exam (content specifications implemented September 1, 2025) includes documentation of medical history and clinical physical findings. Those items are not paperwork trivia. The radiologist reads what you marked and what you wrote. A mole that is not circled becomes a possible mass. A lumpectomy scar that is not lined becomes architectural distortion. A gender-affirming surgery that is not recorded sends the wrong tissue down a default screening pathway. You are not expected to manage oncology. You are expected to collect the order , the surgery , the findings on the skin , and the anatomy that is actually present , then make those facts visible on the image and in the record.
Imaging Requests Versus What the Patient Says at the Desk
The imaging request (physician order or requisition) is the legal reason the exposure is made. It identifies the patient, laterality when laterality is part of the order, and the indication . In breast imaging that indication is usually screening or diagnostic .
Screening means the patient is asymptomatic and the study is a routine search for occult cancer, typically a two-view exam of each breast. Diagnostic means there is a problem to solve: a lump, focal pain, nipple discharge, a callback from screening, short-interval follow-up, or additional evaluation of an implant or postoperative breast. The indication controls protocol, extra views, whether ultrasound is paired, and how the examination is billed. A mammographer who always takes the same four pictures regardless of the order is not practicing to the blueprint.
The desk interview is a second, independent data source. Patients add facts the order never listed: a lump found in the shower, a scar they forgot to mention, hormones started after the last visit, or films that live at another hospital. Those statements do not silently overwrite the order, and the order does not erase the new lump.
Source What it carries Mammographer action
Written order Screening versus diagnostic indication and ordered laterality Follow it for protocol until a licensed provider amends the order
Patient report at the desk Symptoms, surgeries, hormones, implants, where priors live Record in the patient's words; escalate new problems the same day
Visual inspection Scars, moles, tattoos, contour, skin color and dimpling Place markers and complete a diagram before compression
If the order says screening and the patient reports a new lump , document the lump, mark it, and notify the radiologist or ordering pathway so the study can be converted to diagnostic workup. Do not send an asymptomatic screening hanging protocol on a symptomatic breast. If the order is already diagnostic for a six-o'clock mass and the patient says she feels fine, you still perform the diagnostic protocol and still record her statement. Identity, gender, or anxiety does not choose screening versus diagnostic. The order does, amended when new clinical information requires it.
Verify that the order matches the correct patient (name and date of birth) before you mark skin or expose. Wrong-patient history is as dangerous as wrong-site laterality.
Previous Breast Surgery: Lumpectomy and Augmentation
ARRT's history list gives two surgery examples: lumpectomy and augmentation . Ask which breast, what year, and what the patient understands was removed or placed.
Lumpectomy is breast-conserving removal of a tumor with a surrounding margin of tissue. Expect a skin scar, a possible volume defect, and often surgical clips at the lumpectomy bed. Those clips are landmarks, not dirt to wipe off the skin. Tenderness and reduced compressibility near the scar are common. An axillary incision means lymph nodes were sampled or dissected; that scar will fight you on the mediolateral oblique (MLO).
Augmentation means implants (or rarely other material) were placed to enlarge or reshape breasts that are still present. Implants change how you compress, how much dose automatic exposure control delivers, and whether implant-displaced views are part of the protocol. Ask whether the patient knows saline versus silicone and whether either implant has been revised.
Keep reconstruction after mastectomy for the treatment section. Here you only need to know that tissue is missing, an implant or expander is present, or the chest wall is what you have to image. Reduction mammoplasty, excisional biopsy, and chest-contouring surgery also belong in the history even though they are not the two printed examples. ARRT's examples are a starter list, not a ceiling.
Useful prompts:
Which breast, and is the scar still tight or painful?
Were lymph nodes taken from the armpit?
Are there implants, expanders, or both?
Was the breast irradiated (skin may be thin and fragile)?
Clinical Findings: Radiopaque Markers and Diagrams
ARRT asks you to document clinical findings , with examples lumps, scars, moles, tattoos, and abnormalities . Two methods work together: radiopaque skin markers that photograph onto the mammogram, and a breast diagram (paper or electronic) that records clock-face position, centimeters from the nipple, and size. A marker without a note can be misread. A note without a marker can be missed on a busy workstation. Use both unless your written protocol says otherwise for a specific finding.
Follow the facility shape protocol . A widely taught convention, used so any radiologist can decode the image, is:
Finding How to mark What to write on the diagram or history
Palpable lump Triangle over the lump Clock position, cm from nipple, approximate size, who felt it, how long it has been present
Surgical scar Thin radiopaque line along the scar Procedure, year, laterality, breast versus axilla
Raised mole or skin tag Circle around the lesion Stops a cutaneous density from being called an intramammary mass
Nipple not in profile Small BB or pellet on the nipple Prevents the nipple from mimicking a mass and supports distance measurements
Focal pain without a lump Facility-designated shape distinct from the lump triangle The exact site the patient indicates with one finger
Tattoo, decorative ink, or piercing remnant Mark if it will project as a density; otherwise diagram-only per protocol Location and that the pigment is cutaneous
Other abnormality (new nipple inversion, dimpling, erythema, peau d'orange) As directed; do not bury the finding under a huge marker New versus longstanding; notify the radiologist before the patient leaves if inflammatory signs are present
Place markers before compression so they do not slide. Use mammography-rated, typically non-metallic markers so they do not bloom into a huge artifact. If you circle a mole, the radiologist can dismiss a skin density. If you skip the circle, you invite a callback. If you put a triangle on a mole, you have labeled a skin finding as a palpable mass. That mismatch is a known source of false interpretation.
Tattoos can be faintly dense or can overlay parenchyma. You still document them. You do not need a marker on every square centimeter of ink if protocol is diagram-only, but you never pretend the tattoo is not in the field.
Gender Affirmation: Surgery and Hormonal Therapy
ARRT lists gender affirmation with examples surgery and hormonal therapy . Record them as medical history because they change remaining breast tissue and the screening pathway the order should follow. They do not change courtesy, name use, or identity checks.
Hormonal therapy may be feminizing (estrogen, often with an anti-androgen) or masculinizing (testosterone). Glandular tissue can increase or decrease over months to years. Duration is clinically relevant. American College of Radiology appropriateness materials commonly treat about five or more years of feminizing hormones, together with usual screening age (often 40 years for average risk), as the setting in which screening mammography may be appropriate for transfeminine patients. Shorter hormone exposure often is not a screening-mammography pathway. You do not independently start a screening program. You document years of hormones , current use, and how much breast tissue you can position so the order and the interpretation match the anatomy in the room.
Surgery may include augmentation with implants, reduction, or chest masculinization (top surgery). Chest masculinization is usually a contouring operation that leaves residual breast tissue; it is not automatically the same as an oncologic mastectomy. After substantial tissue removal, screening mammography is often not feasible. A palpable area is then typically a diagnostic problem, often ultrasound if ordered. Patients who retain breasts generally follow the same screening logic as other patients with intact breasts, according to the order they arrive with. Document nonbinary patients by anatomy and hormones rather than forcing a binary label onto the requisition.
Technologist practice:
Verify identity with name and date of birth; use the name and pronouns in the record.
Ask what was operated on and whether breast tissue or implants remain.
Position the tissue you can pull onto the receptor. Do not insist on a textbook craniocaudal and MLO the chest wall cannot produce.
Let the order indication decide screening versus diagnostic. A transfeminine patient can still need diagnostic views for a lump. A transmasculine patient with retained breasts can still be a screening examination.
The scored skill is simple: the request says why the patient is here; the interview and your inspection say what anatomy and findings are present; markers and the diagram leave those facts on the study after the patient has gone.